-
Request for Sample
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
-
“Global Cardiac POC Testing Devices Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028” is a recent report generated by MarketResearch.biz. The global cardiac POC testing devices market report has been segmented on the basis of product type, end-user, and region.
Global Cardiac POC Testing Devices Market: Overview
Point of care testing devices are used for medical diagnostic tests in which the test is done at the place and time of patient care. POC testing devices help in saving the time of the patient as sending the samples to the laboratory and waiting for the resulting is a long process.
Global Cardiac POC Testing Devices Market: Dynamics
Changing healthcare regulatory standards across the globe and practitioners approach towards providing point-of-care diagnostics in order to save time are major factors expected to drive growth of the global cardiac POC testing devices market. In addition, increasing government spending on the development of healthcare infrastructure in order to facilitate advanced healthcare facilities is expected to further support the market growth.
Moreover, changing lifestyle pattern, rising incidences of chronic diseases, and mortality due to cardiovascular diseases is rising across the globe which is resulting in increasing adoption of POC testing devices in order to improve outcomes with more convenient and frequent measurements to keep patients within the therapeutic range of anticoagulant agents is another factor expected to further support market growth to a certain extent.
However, stringent government regulations related to product approval is a major factor expected to hamper growth of the global cardiac POC testing devices market. In addition, lack of healthcare infrastructure in developing countries in order to facilitate advanced facilities and non-favorable reimbursement policies are expected to challenge growth of the global market.
Technological advancements by major players and innovative product offerings are expected to create new opportunities in terms of revenue for players operating in the target market over the forecast period. In addition, growing expansion activities through strategic mergers and acquisitions between regional and international players in order to enhance product portfolio is expected to further support market growth. In 2017, Siemens Healthineers Inc. acquired Epocal Inc. that develops and provides point-of-care blood diagnostic systems for healthcare enterprises. This acquisition will help the company to expand its product portfolio in POC testing devices.
Global Cardiac POC Testing Devices Market: Segment
Among the product type segments, the analyzers segment is expected to dominate in the target market over the forecast period.
Among the end-user segments, the hospital's segment is expected to dominate in the target market over the forecast period.
Global Cardiac POC Testing Devices Market: Region
The market in North America is expected to dominate in the global cardiac POC testing devices market and is expected to continue its dominance over the forecast period. This can be attributed to well-developed healthcare infrastructure in order to facilitate advanced healthcare services, favorable reimbursement policies, and the presence of major players operating in countries in this region. In addition, business development activities through partnership and agreements are expected to further support market growth in this region.
The market in Asia Pacific is expected to witness faster growth, owing to increasing government spending on the healthcare sector, innovative product offerings by prominent players operating in emerging economies in this region.
Global Cardiac POC Testing Devices Market Segmentation
Segmentation by product type
- Cardiac Markers Test
- Cardiac troponin (cTn) Test
- Myoglobin Test
- Creatine kinase MB isoenzyme (CK-MB) Test
- Combinational Test Kits
- Brain natriuretic peptide (BNP) Test
- Analyzers
Segmentation by end user
- Research Laboratories
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Laboratories
Segmentation by region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn - Cardiac Markers Test
-
- Abbott Laboratories
- Medtronic, Inc.
- BG Medicine Inc.
- Roche Diagnostics Corporation
- Siemens Healthineers, Inc.
- Nexus Dx, Inc.
- Lifesign LLC
-
Request for TOC
OUR CLIENTS
Don't just take our word. We are trusted by these great companies!